Search

Search Constraints

You searched for: Author/Creator Boix, Loreto

Search Results

1. Akt‐mediated foxo1 inhibition is required for liver regeneration. Issue 5 (18th December 2015)

2. Bespoken Nanoceria: An Effective Treatment in Experimental Hepatocellular Carcinoma. Issue 4 (14th October 2020)

3. Early diarrhoea under sorafenib as a marker to consider the early migration to second‐line drugs. Issue 6 (6th July 2021)

4. Early diarrhoea under sorafenib as a marker to consider the early migration to second‐line drugs. Issue 6 (6th July 2021)

5. Pharmacokinetics and pharmacogenetics of sorafenib in patients with hepatocellular carcinoma: Implications for combination trials. (25th July 2020)

6. Prospective validation of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in liver biopsies for diagnosis of very early hepatocellular carcinoma. Issue 10 (27th January 2012)

8. The pituitary tumour‐transforming gene 1/delta‐like homologue 1 pathway plays a key role in liver fibrogenesis. (30th January 2022)